INSP logo

INSP EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-4.73%
INSP TTM EBITDA YoY % (-15.35% → -4.73%)
High-resolution chart · PNG

INSP ebitda growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Inspire Medical Systems, Inc. Common Stock EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
-4.7318%
-18.5712%
-3.451%
96.1617%
606.3983%
997.3816%
584.4256%
243.2925%
133.1179%
72.3486%
58.1175%
36.4542%
7.039%
-1.9128%
-5.4603%
-5.1615%
8.6176%
28.0157%
28.6472%
21.5217%
18.5014%
-40.3626%
-76.9623%
-112.9158%
-138.8662%
-85.6929%
-68.711%
-46.6055%
-28.5071%
-24.4134%
-15.3518%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.